--Breaking down diabetes: Drugs for diabetes, starting with the best - metformin
This post written by Randall Stafford, professor of medicine and director of the Program on Prevention Outcomes and Practices, examines metformin, one of the best performing medications to treat diabetes. This is part of a series of blog posts discussing pre-diabetes and Type-2 diabetes.
Stanford Medicine News, 02/26/2018
--Stanford Medicine magazine explores challenges of breaking boundaries in science
The winter issue of Stanford Medicine magazine highlights science that pushes boundaries to save lives and considers ethical questions that are a fundamental part of research.
--Breaking down diabetes: The importance of complications
The post written by Randall Stafford, professor of medicine and director of the Program on Prevention Outcomes and Practices, takes a look at complications from diabetes and best strategies to manage them. This is fourth in a series of blog posts discussing pre-diabetes and Type 2 diabetes.
IEEE Spectrum, 01/16/18
--Stanford’s AI predicts death for better end-of-life care
Stanford researchers are using artificial intelligence algorithms to predict the mortality of patients in time for palliative care physicians to identify and treat patients who could benefit from end-of-life care. This article references Stephanie Harman, clinical associate professor of medicine, and Nigam Shah, associate professor of medicine and of biomedical data science.
--Breaking down diabetes: How to prevent complications
This post written by Randall Stafford, professor of medicine and director of the Program on Prevention Outcomes and Practices, examines strategies to avoid complications of diabetes. This is fifth in a series of eight blog posts discussing pre-diabetes and Type 2 diabetes.
Associated Press, 01/25/18
--Scientists successfully clone monkeys; are humans up next?
Researchers from the Chinese Academy of Sciences in Shanghai have successfully used the cloning technique used to produce Dolly the sheep to create healthy monkeys. Hank Greely, with the Stanford Center for Biomedical Ethics, provides comment here and in articles from HealthDay News and the New York Post.
Read on Healthy Day and New York Times
The Six Fifty, 01/23/18
--Frankenstein@200: Stanford explores the futurism of a centuries-old novel
This Q&A features the Frankenstein@200 series hosted by Stanford Medicine’s Medicine and the Muse program. Audrey Shafer, professor of anesthesiology, perioperative and pain medicine and founder and director of the Medicine in the Muse program, and Joshua Stanley, program coordinator for Medicine and the Muse, are included.